The Flow and Image Cytometry Resource provides advanced flow cytometric and morphologyservice at the light and electron microscope (EM) levels of resolution utilizing state-of-the-art technology andan extensive computer network that has been assembled into a user-friendly environment. The Resource issupervised by Paul K. Wallace, PhD, and Hans Minderman, PhD, and is staffed by five technical personnel.The goal is to provide (i) multiparameter flow cytometry, encompassing analytical, sorting and Luminexservices, (ii) morphological services at the light and EM levels of resolution, and (iii) instruction and technicalsupport as required by investigators. As a focal point for many interdisciplinary activities throughout RPCI,the Resource supports both basic research and clinical protocol services. The Resource has an extensiveimmunophenotyping service and is the core flow cytometric laboratory for many NIH-initiated national clinicaltrials.The Flow Cytometry Component of the Resource offers both clinical and basic research supportservices, which universally maintain a quality assurance program using guidelines from state and nationalaccrediting agencies. The Imaging Component enables qualitative and quantitative image analysis on thetissue, cellular and subcellular levels, time-kinetic multicolor image analysis and quantitative multispectralimage analysis. The Educational Program Component provides didactic lectures and hands-on experiencewith (i) isolation, preparation, and staining of all types of human and animal cells, (ii) instrument setup andacquisition, and (iii) data analysis,The Resource has complete general biology, tissue culture, optics and electronics, and computerlaboratories, as well as a fabrication shop. The Resource's strategic plan emphasizes the provision of stateof-the-art technology and expertise in all facets of flow and image cytometry, and supporting the needs ofCCSG Program members to enhance peer-reviewed funding and publications.During the reporting period (4/1/06 to 3/31/07), the Resource contributed to the research of 67investigators from all six CCSG Programs, with 85% of Resource utilization by CCSG Program memberswith peer-reviewed funding. $110,245 in CCSG support is requested, representing 8% of the total operatingbudget.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016056-32
Application #
7714416
Study Section
Subcommittee G - Education (NCI)
Project Start
2008-07-28
Project End
2013-04-30
Budget Start
2008-07-28
Budget End
2009-04-30
Support Year
32
Fiscal Year
2008
Total Cost
$92,664
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
824771034
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Mayor, Paul C; Eng, Kevin H; Singel, Kelly L et al. (2018) Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network Registry. J Allergy Clin Immunol 141:1028-1035
Dasgupta, Subhamoy; Rajapakshe, Kimal; Zhu, Bokai et al. (2018) Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer. Nature 556:249-254
La Shu, Shin; Yang, Yunchen; Allen, Cheryl L et al. (2018) Metabolic reprogramming of stromal fibroblasts by melanoma exosome microRNA favours a pre-metastatic microenvironment. Sci Rep 8:12905
Zhang, Dingxiao; Tang, Dean G; Rycaj, Kiera (2018) Cancer stem cells: Regulation programs, immunological properties and immunotherapy. Semin Cancer Biol 52:94-106
Gabriel, Emmanuel; Attwood, Kristopher; Al-Sukhni, Eisar et al. (2018) Age-related rates of colorectal cancer and the factors associated with overall survival. J Gastrointest Oncol 9:96-110
Ma, Wen Wee; Xie, Hao; Fetterly, Gerald et al. (2018) A Phase Ib Study of the FGFR/VEGFR Inhibitor Dovitinib With Gemcitabine and Capecitabine in Advanced Solid Tumor and Pancreatic Cancer Patients. Am J Clin Oncol :
Chen, George L; Carpenter, Paul A; Broady, Raewyn et al. (2018) Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host Disease. Biol Blood Marrow Transplant 24:373-380
Eng, Kevin H; Szender, J Brian; Etter, John Lewis et al. (2018) Paternal lineage early onset hereditary ovarian cancers: A Familial Ovarian Cancer Registry study. PLoS Genet 14:e1007194
Barger, Carter J; Zhang, Wa; Sharma, Ashok et al. (2018) Expression of the POTE gene family in human ovarian cancer. Sci Rep 8:17136
Bucsek, Mark J; Giridharan, Thejaswini; MacDonald, Cameron R et al. (2018) An overview of the role of sympathetic regulation of immune responses in infectious disease and autoimmunity. Int J Hyperthermia 34:135-143

Showing the most recent 10 out of 1555 publications